Current Studies

As part of our commitment to be a leader in women’s health care, we continually conduct clinical research studies to advance treatment methods and to identify the most effective means to care for patients.We want to be on the cutting edge of medicine and contribute, first-hand, to benefit not only Rosemark patients but also patients around the world. Rosemark Clinical Research is now enrolling participants in investigational drug studies in the following areas:

Uterine Fibroid

The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Enroll

Recurrent Yeast Infection

Recurrent vulvovaginal candidiasis (RVVC), also known as recurrent yeast infections, is defined as at least 3 episodes of acute VVC in the past 12 months. Several properties of VT-1161 suggest it might be a safer and more effective treatment of RVVC than other oral antifungal medications. Enroll

Endometriosis Study MT-2990

The purpose of this study is to assess the safety and efficacy of MT- 2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis. Enroll

FemBloc Contraception

FemBloc Contraception
Seeking subjects who want permanent birth control Enroll

Uterine Fibroids

heavy periods uterine fibroids
Seeking subjects with Heavy Menstrual Bleeding Associated with Uterine Fibroids Enroll

ENDOMETRIOSIS (Observational)

smiling woman
Bone mineral density observation for subjects treated for endometriosis. Info

Hot Flash

Hot Flash
Seeking subjects with moderate to severe hot flashes associated with menopause Info

E4 Freedom Contraception

e4 freedom contaception
      This study is evaluating how safe and effective the study pill is at preventing pregnancy, and what periods are like during the menstrual cycle while taking it. Info